Results 151 to 160 of about 118,844,745 (215)

Phylogenetic Study of Local Patterns Influenza A(H3N2) Virus Transmission in a Semi-Isolated Population in a Remote Island in Japan Between 2011 and 2013. [PDF]

Influenza Other Respir Viruses
Han SM, Shiino T, Masuda S, Furuse Y, Yasaka T, Kanda S, Komori K, Saito N, Kubo Y, Smith C, Endo A, Robert A, Baguelin M, Ariyoshi K.   +13 more
europepmc   +1 more source

Local patterns of spread of influenza A H3N2 virus in coastal Kenya over a 1-year period revealed through virus sequence data. [PDF]

Sci Rep
Owuor DC, Ngoi JM, Nyasimi FM, Murunga N, Nyiro JU, Chaves SS, Nokes DJ, Agoti CN.   +7 more
europepmc   +1 more source

Corrigendum: The high-throughput solid-phase extraction of <i>cis</i>-cyclo(L-Leu-L-Pro) and <i>cis</i>-cyclo(L-Phe-L-Pro) from <i>Lactobacillus plantarum</i> demonstrates efficacy against multidrug-resistant bacteria and influenza A (H3N2) virus. [PDF]

Front Mol Biosci
Son J, Hong Y, Seong H, Oh YS, Kwak MK.
europepmc   +1 more source

Human-to-Human Transmission of Influenza A(H3N2) Virus with Reduced Susceptibility to Baloxavir, Japan, February 2019. [PDF]

Emerg Infect Dis, 2019
Takashita E, Ichikawa M, Morita H, Ogawa R, Fujisaki S, Shirakura M, Miura H, Nakamura K, Kishida N, Kuwahara T, Sugawara H, Sato A, Akimoto M, Mitamura K, Abe T, Yamazaki M, Watanabe S, Hasegawa H, Odagiri T.   +18 more
europepmc   +1 more source

The high-throughput solid-phase extraction of <i>cis</i>-cyclo(L-Leu-L-Pro) and <i>cis</i>-cyclo(L-Phe-L-Pro) from <i>Lactobacillus plantarum</i> demonstrates efficacy against multidrug-resistant bacteria and influenza A (H3N2) virus. [PDF]

Front Mol Biosci
Son J, Hong Y, Seong H, Oh YS, Kwak MK.
europepmc   +1 more source

A Dose-finding Study of a Wild-type Influenza A(H3N2) Virus in a Healthy Volunteer Human Challenge Model. [PDF]

Clin Infect Dis, 2019
Han A, Czajkowski LM, Donaldson A, Baus HA, Reed SM, Athota RS, Bristol T, Rosas LA, Cervantes-Medina A, Taubenberger JK, Memoli MJ.   +10 more
europepmc   +1 more source

VirPLM: antigenic prediction of influenza A/H3N2 viruses with a fine-tuned protein language model. [PDF]

Bioinformatics
Li X, Xiao K, Zhou C, Jia X, Zhao D, Xu J, Zeng X, Shi J, Shang X, Zhu J, Kong H.   +10 more
europepmc   +1 more source

Clinical outcomes during the 2025-2026 and 2024-2025 influenza seasons in a US EHR network: an ecological comparison during A(H3N2) subclade K predominance. [PDF]

IJID Reg
Kitano T, Yoshida S.
europepmc   +1 more source

Effects of Age and Birth Cohort on Influenza A Virus Subtype-Specific Hospitalization Rates, United States, 2010-2025. [PDF]

J Infect Dis
O'Halloran A, Hood N, Ujamaa D, Merced-Morales A, Gurbaxani B, Kirley PD, Napoles MJ, Alden NB, Aragon D, Meek J, Yousey-Hindes K, Openo KP, Witt LS, Monroe ML, Ryan PA, Leegwater L, Rojewski S, Kenyon C, Lynfield R, Poblete M, Landis ZQ, Anderson BJ, Rowe AJ, Felsen CB, Tesini BL, Harbi K, Wilson E, Lung K, Moran NE, Sutton M, Thomas A, Talbot HK, Schaffner W, Crossland M, Olsen K, Patel M, Fry AM, Kondor R, Bozio C, Reed C, Brammer L, Budd A, Flannery B, Garg S.   +43 more
europepmc   +1 more source

A Cell-Based ELISA for High-Throughput Screening of Inhibitors Blocking Influenza Virus Attachment to the Subtype-Independent α2,6-Sialic Acid Receptor. [PDF]

Int J Mol Sci
Guo K, Wu J, Liu Y, Luo J, Jiang W, Wang C, Sheng R, Li S, Fan X, Wu Y, Xu Y, Si S, Zhang Y, Zhang J.   +13 more
europepmc   +1 more source